Lhasa Limited shared knowledge shared progress
Loading...
PublicationsJump to results
Authors
Publication Type
Publication Year
Related event
Related Products
Reset
TitlePublishedTypeProducts
ICH M7 Use CasesJune 2018pdf fileDerek NexusSarah Nexus
ICH M7 Workflow.pdfNovember 2015pdf fileDerek NexusSarah NexusVitic Nexus
Identification of Adverse Outcome Pathways for the Nephrotoxicity of Nucleoside and Nucleotide Anti-Viral DrugsMarch 2014pdf fileDerek Nexus
Implementation of ICH M7 Recommended (Q)SAR AnalysesMarch 2016pdf fileDerek NexusSarah NexusVitic NexusZeneth
Important considerations for the validation of QSAR models for in vitro mutagenicityNovember 2018Derek NexusSarah NexusVitic Nexus
Improvement of quantitative structure–activity relationship (QSAR) tools for predicting Ames mutagenicity: outcomes of the Ames/QSAR International Challenge ProjectOctober 2018Derek NexusSarah Nexus
Improvements to in silico mutagenicity predictivity of aromatic amines with access to proprietary dataMarch 2016pdf fileDerek Nexus
Improvements to in silico predictivity after access to proprietary dataApril 2016Derek Nexus
Improvements to In Silico Skin Sensitization Predictivity After Access to Proprietary DataMarch 2016pdf fileDerek Nexus
Improving Toxicity Predictions through knowledge and data sharingJune 2018pdf fileDerek NexusExcipientsIntermediatesiPiEVitic Nexus
In Silico Analysis Of A Human Cardiac Adverse Effects Data Set.pdfJune 2010pdf fileDerek Nexus
In silico approaches to knowledge and data sharingOctober 2015pdf fileDerek NexusSarah Nexus
In silico prediction of the skin sensitisation potential of non-quinonoid Michael acceptors: new reactivity assessments and evidence based precursor selectionSeptember 2017pdf fileDerek Nexus
In Silico Predictions For GenotoxicityOctober 2018pdf fileDerek NexusSarah Nexus
In Silico Strategies to Assess Potentially Mutagenic Impurities Under ICH M7March 2017pdf fileDerek NexusSarah NexusMirabilisVitic Nexus
In silico systems conforming to the OECD Principles for (Q)SAR Validation.pdfNovember 2010pdf fileDerek Nexus
In Silico Systems For The Prediction Of ToxicityJanuary 2013pdf fileDerek Nexus
In silico toxicity profiling of natural product compound libraries from African flora with anti-malarial and anti-HIV propertiesFebruary 2018Derek Nexus
Integrated hazard identification of chemical sensitizers using in vitro and in silico readouts - A comparative evaluation of predictive performanceAugust 2017pdf fileDerek Nexus
Integrating Knowledge Of Carcinogenicity Adverse Outcome Pathways (AOPs) With Experimental DataOctober 2018pdf fileDerek NexusVitic Nexus
Introduction to in silico toxicologyOctober 2014Derek NexusSarah Nexus
Investigating Adverse Outcome Pathway Models for Mitochondrial Toxicity.wmvMay 2013Derek Nexus
Investigating the Role of Mitochondrial Toxicity in Drug-Induced Liver Injury via Congruent Structure-Activity relationships.March 2011pdf fileDerek NexusMIP DILI
Investigation of Structure-Activity Relationships for Mitochondrial Toxicity.pdfSeptember 2010pdf fileDerek Nexus
Is preclinical data sharing the new norm?May 2016Derek NexusETOXExcipientsIntermediatesMeteor NexusVitic Nexus

© 2018 Lhasa Limited | Registered office: Granary Wharf House, 2 Canal Wharf, Leeds, LS11 5PS, UK Tel: +44 (0)113 394 6020
VAT number 396 8737 77 | Lhasa Limited is registered as a charity (290866)| Company Registration Number 01765239 (England and Wales).

Thanks to QuestionPro's generosity, we now have survey software that powers our data intelligence.

IP: 54.227.31.145 | Group: ###groupid###